{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680936",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680936_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"acarbose\" outputclass=\"int-drug\">acarbose</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  acarbose  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acarbose</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680937",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680937_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"canagliflozin\" outputclass=\"int-drug\">canagliflozin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  canagliflozin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Canagliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680938",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680938_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"dapagliflozin\" outputclass=\"int-drug\">dapagliflozin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  dapagliflozin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dapagliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680939",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680939_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"dulaglutide\" outputclass=\"int-drug\">dulaglutide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  dulaglutide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dulaglutide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680940",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680940_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"empagliflozin\" outputclass=\"int-drug\">empagliflozin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  empagliflozin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Empagliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680941",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680941_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"ertugliflozin\" outputclass=\"int-drug\">ertugliflozin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  ertugliflozin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ertugliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680942",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680942_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"exenatide\" outputclass=\"int-drug\">exenatide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  exenatide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Exenatide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680943",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680943_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"glibenclamide\" outputclass=\"int-drug\">glibenclamide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  glibenclamide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Glibenclamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680944",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680944_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"gliclazide\" outputclass=\"int-drug\">gliclazide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  gliclazide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gliclazide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680945",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680945_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"glimepiride\" outputclass=\"int-drug\">glimepiride</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  glimepiride  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Glimepiride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680946",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680946_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"glipizide\" outputclass=\"int-drug\">glipizide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  glipizide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Glipizide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680947",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680947_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"insulins\" outputclass=\"int-drug\">insulins</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  insulins  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Insulins</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680948",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680948_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"linagliptin\" outputclass=\"int-drug\">linagliptin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  linagliptin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Linagliptin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680949",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680949_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"liraglutide\" outputclass=\"int-drug\">liraglutide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  liraglutide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Liraglutide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680950",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680950_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"lixisenatide\" outputclass=\"int-drug\">lixisenatide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  lixisenatide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lixisenatide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680951",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680951_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"metformin\" outputclass=\"int-drug\">metformin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  metformin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metformin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680952",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680952_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"nateglinide\" outputclass=\"int-drug\">nateglinide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  nateglinide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nateglinide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680953",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680953_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"pioglitazone\" outputclass=\"int-drug\">pioglitazone</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  pioglitazone  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pioglitazone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680954",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680954_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"repaglinide\" outputclass=\"int-drug\">repaglinide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  repaglinide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Repaglinide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680955",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680955_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"saxagliptin\" outputclass=\"int-drug\">saxagliptin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  saxagliptin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Saxagliptin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680956",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680956_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"semaglutide\" outputclass=\"int-drug\">semaglutide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  semaglutide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Semaglutide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680957",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680957_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"sitagliptin\" outputclass=\"int-drug\">sitagliptin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  sitagliptin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sitagliptin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680958",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680958_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"tolbutamide\" outputclass=\"int-drug\">tolbutamide</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  tolbutamide  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tolbutamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680959",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2#bnf_i1557280680959_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"alogliptin\" outputclass=\"int-heading-drug\">alogliptin</ph> and <ph otherprops=\"vildagliptin\" outputclass=\"int-drug\">vildagliptin</ph> can increase the risk of hypoglycaemia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  alogliptin  and  vildagliptin  can increase the risk of hypoglycaemia. \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vildagliptin</title>"
					}
				}
			],
			"hasSearchLabel": " Alogliptin  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/alogliptin-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Alogliptin </title>"
			},
			"rdfs:label": "alogliptin"
		}
	]
}